Healthy Skepticism Library
Items published during the years 1970 to 1979
There are 379 items in the Healthy Skepticism Library that were published during the years 1970 to 1979.
Page 1 of 4 pages 1 2 3 > Last ›
HSL3024
 Chapman S.
 Prescription drug advertising
 Medical Journal of Australia 1979 Nov 29; 66:700
HSL3023
 Ferris JD.
 Prescription drug advertising
 Medical Journal of Australia 1979 Nov 17; 66:550
HSL2990
 Feinstein AR, Horwitz RI.
 Avoiding conflicts of interest in drug research.
 N Engl J Med 1979 Nov 1; 301:(18):1009
HSL2993
 Greenberg BG.
 Avoiding conflicts of interest in drug research.
 N Engl J Med 1979 Nov 1; 301:(18):1008
HSL3004
 Relman AS.
 Who reviews the ads?
 N Engl J Med 1979 Nov 1; 301:(18):999
HSL3022
 Tannock IF.
 Responsibility in advertising: an oncologist's view
 New England Journal of Medicine 1979 Nov 1; 300:1004
HSL2987
 Chapman S.
 Advertising and psychotropic drugs: the place of myth in ideological reproduction.
 Soc Sci Med [Med Psychol Med Sociol] 1979 Nov; 13A:(6):751-64
HSL3021
 Kleinman G.
 The physician’s drug adoption process re:  product risk
 Medical Marketing & Media 1979 Nov; 14:46, 48-50
HSL16701
 Wolfe S
 The Conflict Between Individual Freedom and Social Control: Saccharin and Food Additives
 Ann N.Y. Acad. Sci 1979 Nov; 329:42‑245
HSL16702
 Wolfe S
 The Dichotomy Between Theory and Practice in Risk/Benefit Analysis
 Ann N.Y. Acad. Sci 1979 Nov; 329:274‑276
HSL8546
 Leclerc Chevalier D
 Ottawa report: Bureau of Drug Quality Assessment 
 Canadian Pharmaceutical Journal 1979 Oct; 112:293-294
HSL8550
 Fink JL.
 Marketing in a generic environment: pharmacist's view 
 Medical Marketing and Media 1979 Oct; 14:40, 42, 44, 46
HSL3017
 Dukes MN.
 Identifying the medical consultants of pharmaceutical companies.
 Lancet 1979 Sep 29; 2:(8144):696
HSL2991
 Fitzgerald FT.
 Detail men in white coats.
 N Engl J Med 1979 Sep 20; 301:(12):668
HSL3016
 Burley DM.
 Identifying the medical consultants of pharmaceutical companies.
 Lancet 1979 Aug 18; 2:(8138):354
HSL3002
 Petsonk EL.
 Conflicts of interest in drug research.
 N Engl J Med 1979 Aug 9; 301:(6):335
HSL8551
 Barbieri J.
 New prescription drug labeling requirement 
 US Pharmacist 1979 Aug; 4:19-21
HSL3015
 Lunde PK, Herxheimer A.
 Identifying the medical consultants of pharmaceutical companies.
 Lancet 1979 Jul 28; 2:(8135):197
HSL3008
 Solomon F, Mendelson WB.
 Sleeping pills.
 N Engl J Med 1979 Jul 26; 301:(4):214-5
HSL3014
 Kelly NR.
 Prescription drug advertising
 Medical Journal of Australia 1979 Jul 14; 66:40
HSL3006
 Schwartz H.
 Junk mail.
 N Engl J Med 1979 Jul 5; 301:(1):53
HSL3007
 Snead OC.
 Junk mail.
 N Engl J Med 1979 Jul 5; 301:(1):53
HSL3010
 Stock SL.
 Junk mail.
 N Engl J Med 1979 Jul 5; 301:(1):53
HSL8547
 Najman JM, Siskind V, Bain C.
 Prescription drug advertising: medical journal practices under different types of control.
 
Med J Aust 1979 May 19; 1:(10):420-4
HSL2988
 Christensen DB, Wertheimer AI.
 Sources of information and influence on new drug prescribing among physicians in an HMO.
 Soc Sci Med 1979 May; 13A:(3):313-22
HSL2980
 Binns TB, Smith A.
 Medical representatives.
 Br Med J 1979 Apr 28; 1:(6171):1134-5
HSL3005
 Relman AS.
 The sulindac story: what is medical news?
 N Engl J Med 1979 Mar 29; 300:(13):733-4
HSL3011
 Thompson EL.
 Sexual bias in drug advertisements.
 Soc Sci Med 1979 Mar; 13A:(2):187-91
HSL8541
 Independents: holding their own 
 National Association of Retail Druggists Journal 1979 Mar; 101:23-24
HSL3012
 Wasner C, Kotzin B.
 Sulindac "public relations" deplored.
 N Engl J Med 1979 Feb 15; 300:(7):373
HSL1878
 Kaplan NM.
 Sounding Boards.The support of continuing medical education by pharmaceutical companies
 N Engl J Med 1979 Jan 25; 300:(4):194-6
HSL3009
 Solomon SD, Grimmett BL, Maurer KH, Levin NW.
 Complaint about promotion of new anti-arthritic drug.
 N Engl J Med 1979 Jan 25; 300:(4):203
HSL2996
 Lion JR, Regan BL, Taylor RJ, Kutzer DJ.
 Psychiatrists' opinions of psychotropic drug advertisements.
 Soc Sci Med [Med Psychol Med Sociol] 1979 Jan; 13A:(1):123-5
HSL2989
 Editor .
 Publicity about sulindac [Editor's reply]
 New England Journal of Medicine 1979; 300:(13):735
HSL2992
 Frisof KB, Parnicky K.
 The burden of junk mail
 New England Journal of Medicine 1979; 300:865-866
HSL2994
 Hughes R, Brewin R.
 The tranquilizing of America:  pill popping and the American way of life
 1979; 
HSL2995
 Kaplan NM.
 The support of continuing medical education by pharmaceutical companies
 New England Journal of Medicine 1979; 300:194-196
HSL2997
 Lobo F.
 Monopolistic structures and industrial analysis in Spain: the case of the pharmaceutical industry.
 Int J Health Serv 1979; 9:(4):663-82
HSL2998
 Mallace AH.
 Publicity about sulindac [2nd of 4 letters]
 New England Journal of Medicine 1979; 300:(13):734
HSL2999
 Martin RW.
 Diuretic equivalence of frusemide preparations
 New Zealand Medical Journal 1979; 90:209
HSL3000
 Miller DR.
 Publicity about sulindac [3rd of 4 letters]
 New England Journal of Medicine 1979; 300:(13):735
HSL3001
 Miller JA, Waller R.
 Health care advertising: consumer vs. physician attitudes
 Journal of Advertising 1979; 8:(4):20-29
HSL3003
 Pyeritz RE.
 The burden of junk mail
 New England Journal of Medicine 1979; 301:866
HSL9077
 Medawar C.
 Insult or Injury
 London: Social Audit 1979
http://www.amazon.co.uk/Insult-Injury-Charles-Medawar/dp/0950339210/ref=sr_1_6/026-0515181-7375631?ie=UTF8&s=books&qid=1175254557&sr=1-6
HSL2958
 Green B.
 The politics of psychoactive drug use in old age.
 Gerontologist 1978 Dec; 18:(6):525-30
HSL2964
 Kunin CM.
 Clinical investigators and the pharmaceutical industry.
 Ann Intern Med 1978 Nov; 89:(5):
HSL8559
 Kunin CM.
 Problem of antibiotic usage. Definitions, causes, and proposed solutions
 Ann Intern Med. 1978 Nov; 89:(5):802-5.
HSL2963
 Kalb CC.
 Psychological motivations in physician prescribing habits.
 Med Mark Media 1978 Oct; 13:(10):43-5,
HSL8549
 Kalb CL.
 Psychological motivations in physician prescribing habits 
 Medical Marketing and Media 1978 Oct; 13:43-45, 49, 50, 52, 54, 55
HSL8553
 What companies do pharmacists now select when filling Rx's for 16 generic drugs? Part 2 
 Pharmacy Times 1978 Oct; 44:45-49
HSL2314
 Dajda R.
 Drug advertising and prescribing.
 J R Coll Gen Pract 1978 Sep; 28:(194):538-41
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=739456&query_hl=23
HSL2973
 Talley CR.
 Hospitals defend formulary decisions against industry attacks.
 Am J Hosp Pharm 1978 Sep; 35:(9):1154-5
HSL8552
 What companies do pharmacists now select when filling Rx's for 16 generic drugs? Part 1 
 Pharmacy Times 1978 Sep; 44:54-58
HSL16700
 Wolfe S
 Now, Let the Victim Beware
 Mother Jones 1978 Sep14-18
HSL2972
 Shearer SW, Gagnon JP, Eckel FM.
 Community, hospital and clinical pharmacists and drug information centers as physician drug information sources.
 Am J Hosp Pharm 1978 Aug; 35:(8):909-14
HSL2976
 Walton H.
 A case for medical journal advertising
 Medical Marketing & Media 1978 Aug; 13:37-43
HSL8560
 Gardner VR, Fulda TR.
 Drug insurance and cost containment: an evaluation of where we're going.
 
Hosp Formul 1978 Jun; 13:(6):460-1,
HSL3013
 Paine TF.
 Advertising (quantified)
  JAMA1979 May 25;241(21):2264 1979 May 25; 241:(21):2264
HSL8548
 Braucher CL.
 Pharmacy ethics-professional idealism and reality 
 American Journal of Pharmaceutical Education 1978 May; 42:141-143
HSL2975
 Peretz SM.
 Medical journal advertising as currently viewed by the pharmaceutical industry.
 J R Soc Med 1978 Apr; 71:(4):282-4
HSL8561
 Annual survey report-research and development activities ethical pharmaceutical industry, 1976 with forecast for 1977 
 Medical Marketing and Media 1978 Mar; 13:17-18, 20-24, 26-30
HSL2957
 Medical journals and advertising
 N Z Med J. 1978 Feb 22; 87:(606):139
HSL8555
 Dolan M.
 Target practice at FDA: talking back to the regulators 
 American Pharmacy 1978 Feb; 36-40
HSL2971
 Roustan PT.
 The pharmaceutical manufacturers representative.
 Drug Inf J 1978 Jan-Mar; 12:(1):15-9
HSL8563
 Garton WM.
 Pharmaceutical industry in Canada: its environment and performance 
 Canadian Pharmaceutical Journal 1978 Jan; 111:6-7
HSL2959
 Harrell GD, Lindsay CM.
 Pharmaceutical marketing
 1978; 69-90
HSL2960
 Holmes JD.
 Drug advertisements information
 New Zealand Medical Journal 1978; 87:226
HSL2961
 Holst H.
 Unsolicited advertising
 Canadian Medical Association Journal 1978; 118:24
HSL2962
 Hornbrook MC.
 Market structure and advertising in the US pharmaceutical industry
 Medical Care 1978; 16:90-109
HSL2965
 Lall S, Bibile S.
 The political economy of controlling transnationals: the pharmaceutical industry in Sri Lanka, 1972-1976.
 Int J Health Serv 1978; 8:(2):299-328
HSL2966
 Larson LN, Smith MC.
 An analysis of the effects of “fair balance” in prescription drug advertising
 Medical Marketing & Media 1978; 13:(6):26-27, 31
HSL2967
 Martin RW.
 Drug advertisements
 New Zealand Medical Journal 1978; 87:295
HSL2968
 Phillips JS.
 Drug advertisements
 New Zealand Medical Journal 1978; 87:102-103
HSL2969
 Rheinstein PH, Hugstad PS.
 The regulation of prescription drug advertising
 1978; 407-416
HSL2970
 Rice DI.
 Misleading advertising of drug products
 Canadian Family Physician 1978; 24:101-102
HSL2974
 Yudkin JS.
 Provision of medicines in a developing country
 Lancet 1978; 1:810-812
HSL2977
 Eastman M.
 The day the detail man talked
 American Pharmacy 1978; 18:(11):592
HSL2978
 Ahmad S, Sheikh AI, Meeran MK.
 Publicity about sulindac [1st of 4 letters]
 New England Journal of Medicine 1978; 300:(13):734
HSL2979
 Bell W.
 Accredited pharmaceutical manufacturers representatives
 Canadian Medical Association Journal 1978; 120:1327
HSL2986
 Blakeslee A.
 Publicity about sulindac [4th of 4 letters]
 New England Journal of Medicine 1978; 300:(13):735
HSL8556
 Presentation of price lists 
 Krankenhaus Apotheke 1978; 28:(2):15-16
HSL8558
 Haines BA.
 Worldwide regulations and legislation; their effects on pharmaceutical product development 
 Drug Development and Industrial Pharmacy 1978; 4:(1):1-30
HSL19891
 Phillips PJ
 Kill or Cure: Lotions, Potions, Characters and Quacks of Early Australia  Richmond, Vic: Greenhouse Publishing 19780
http://www.blaqbooks.com.au/index.php?route=product/product&path=49&product_id=1599
HSL8562
 Wheeler V.
 MSD unveils first computer controlled drug plant 
 Drug Cosmet Ind 1977 Dec; 121:48-50
HSL2932
 Holmes JD.
 Prescribing information in drug advertisements.
 N Z Med J 1977 Nov 23; 86:(600):467-9
HSL2921
 Dixon RB.
 The current status of guidelines for clinical research from the viewpoint of the pharmaceutical industry.
 J Clin Pharmacol 1977 Nov-Dec; 17:(11-12):691-6
http://jcp.sagepub.com/cgi/reprint/17/11/691
HSL8565
 Smith MC.
 Drug product advertising and prescribing: a review of the evidence.
 
Am J Hosp Pharm 1977 Nov; 34:(11):1208-24
HSL2920
 Da Sylva NP.
 Drug information sources for the practicing physician.
 Drug Inf J 1977 Oct-Dec; 11:(4):235-7
HSL2935
 Marchand CR.
 Physician attitudes toward sources of drug information.
 Drug Inf J 1977 Oct-Dec; 11:(4):225-6
HSL2937
 Meadows RJ.
 Drug information: the pharmaceutical manufacturer's viewpoint and involvement.
 Drug Inf J 1977 Oct-Dec; 11:(4):221-4
HSL2943
 Stahl E.
 The medical copywriter in the pharmaceutical industry: an uphill climb after a downhill slide.
 Drug Inf J 1977 Oct-Dec; 11:(4):215-7
HSL2929
 Holland AE.
 Representatives and advertisements as sources of information.
 Postgrad Med J 1977 Sep; 53:(623):559-61
HSL2933
 Kenny EC.
 Information centres in the pharmaceutical industry--the prime source of drug information.
 Postgrad Med J 1977 Sep; 53:(623):562-5
HSL2955
 Brown P.
 Pharmaceutical promotion in Europe - regulations and restrictions
 Medical Marketing & Media 1977 Sep; 12:(9):27, 30, 32, 34, 36, 38
HSL2956
 Smith MC, Strecker P, Hair JF.
 Sex appeals in prescription drug advertising
 Medical Marketing & Media 1977 Sep; 12:(9):64, 66-70
HSL2936
 Martin RW.
 Drug costs.
 N Z Med J 1977 Aug 24; 86:(594):202
HSL2938
 Russell WL, Dahlin PA.
 Industry's interest.
 Drug Intell Clin Pharm 1977 Aug; 11:(8):493-4
HSL2954
 Mergener M.
 Detailmen: Their pharmaceutical knowledge and continuing education
 Medical Marketing & Media 1977 Aug; 12:(8):26, 28-31
HSL2930
 Holmes JD.
 Drug costs.
 N Z Med J 1977 Jul 27; 86:(592):108-9
HSL2953
 Kunin CM.
 Blunder drug for pneumonia.
 N Engl J Med 1977 Jul 14; 297:(2):113-4
Page 1 of 4 pages 1 2 3 > Last ›
